matairesinol has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aittokallio, T; Eckerman, C; Holmbom, B; Laajala, TD; Mäkelä, SI; Polari, L; Saarinen, NM; Smeds, A; Yatkin, E | 1 |
| Eklund, P; Eriksson, JE; Holmbom, T; Peuhu, E; Rivero-Müller, A; Sjöholm, R; Stykki, H; Torvaldson, E; Unkila, M | 1 |
2 other study(ies) available for matairesinol and Cancer of Prostate
| Article | Year |
|---|---|
Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Furans; Heterografts; Humans; Lignans; Male; Mice; Pinus sylvestris; Plant Extracts; Prostatic Neoplasms; Stilbenes; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Cell Polarity; Furans; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Mitochondria; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2010 |